期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非瓣膜性心房颤动患者血栓血液标志物检测及其抗凝治疗进展

Progressionin detecting the blood markers of thrombus and anticoagu-lant therapy in patients with non_valvular atrial fibrillation
下载PDF
导出
作者 刘晓宇
机构地区 河南省人民医院心内科
出处 《河南医学研究》 CAS 2006年第1期71-77,共7页 Henan Medical Research
关键词 非瓣膜性心房颤动 心房颤动患者 标志物检测 抗凝治疗 血栓栓塞 治疗进展 超声心动图检查 血液 独立危险因素 NVAF
分类号 R541.75 [医药卫生—心血管疾病] R512.62 [医药卫生—内科学]
  • 相关文献

参考文献52

  • 1Stroke prevention in atrial fibrillation investigators.Stroke prevention in atrial fibrillation study final results[J].Circulation,1991,84(2):527-539.
  • 2European Atrial Fibrillation Trial Study Group.Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia[ J].N Engl J Med,1995,333(1):5-10.
  • 3Heppell RM,Berkin KE,McLenachan JM,et al.Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in nonrheumatic atrial fibrillation [ J ].Heart,1997,77 (5):407-411.
  • 4Conway DS,Pearce LA,Chin BS,et al.Plasma yon Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation:relationship to stroke risk factors[J].Circulation,2002,106(15):1962-1967
  • 5Conway DS,Pearce LA,Chin BS,et al.Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation[J].Circulation,2003,107(25):3141-3145.
  • 6孙燕淑,祁芸芸.房颤患者血浆vWF、TAT水平测定及临床意义[J].中国医药导刊,2001,3(3):200-201. 被引量：6
  • 7Goette A,Ittenson A,Hoffmanns P,et al.Increased expression of P-selectin in patients with chronic atrial fibrillation[J].Pacing Clin Electrophysiol.2000,23(11 Pt 2):1872-1875.
  • 8Li-Saw-Hee FL,Blann AD,Gurney D,et al.Plasma von Willebrand factor,fibrinogen and soluble P-selectin levels in paroxysmal,persistent and permanent atrial fibrillation:effects of cardioversion and return of left atrial function[J].Eur Heart J,2001,22(18):1741-1747.
  • 9Kamath S,Blann AD,Caine GJ,et al.Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation[J].Stroke,2002,33(5):1237-1242.
  • 10Amiyama N.Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation:rabbit experimental model[ J].Jpn Circ J,1998,62(11):837-843.

二级参考文献60

  • 1王建中,孙芾,王淑娟,杨振华,袁家颖.流式细胞术检测活化血小板[J].中华医学检验杂志,1994,17(4):232-235. 被引量：69
  • 2[1]Lip GYH, Lip PL, Zarifis J, et al. Fibrin D- dimer and Bthromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation: Effects of introducing ultra - lowdose warfarin and aspirin. Circulation, 1996, 94(3): 425～426.
  • 3[2]Daniel WG. Should transesophageal echocardiography be used to guide cardioversion? N Engl J Med, 1993, 328(11): 803～805.
  • 4[4]Sohara H, Amitani S, Kurose M, et al. Atrial fibrillation activates platelets and coagulation in a time - dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol, 1997, 29(1): 106.
  • 5[5]Pongratz G, Bradt- Pohlman M, Henneke KH, et al. Platelet activation in embolic and preembolic status of patients with nonrhuematic atrial fibrillation. Chest, 1997, 111 (4): 929～933.
  • 6[6]Minamino T. Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol, 1999, 83: 194～198.
  • 7Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipeprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ, 1990, 301 : 1248-1251.
  • 8Budde T, Fechtrup C, Bosenberg E, et al. Plasma Lp (a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary artefiography for clinically suspected coronary atherosclerosis. Arteriescler Thromb,1994, 14: 1730-1736.
  • 9Sirikci O, Aytekin V, Demiroglu IC et al. Association of lipoprotein(a) concentration and apo (a) isoform size with restenosis after percutaneous transluminal coronary angloplasty. Int J Clin Lab Res,2000, 30:93-99.
  • 10Miyata M, Biro S, Arima S, et al. High serum concentration of lipoprotein (a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with singlevessel disease. Am Heart J, 1996, 132 (2 Pt 1) :269-273.

共引文献62

河南医学研究
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部